Neurovascular Embolization Devices Market 2024 : Size, Growth Rate, Business Module, Product Scope, Regional Analysis And Expansions 2033

Neurovascular embolization devices are medical instruments used to treat abnormal brain or central nervous blood vessels by blocking or redirecting blood flow. These devices are employed in neuro-interventional procedures to manage conditions such as aneurysms, arteriovenous malformations (AVMs), and arteriovenous fistulas (AVFs) that may risk bleeding or other complications.

Sizing and Forecast
The neurovascular embolization devices market size has grown strongly in recent years. It will grow from $1.15 billion in 2023 to $1.23 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to the increased prevalence of neurovascular disorders, the rising geriatric population, the demand for minimally invasive procedures, improved healthcare infrastructure, and increased healthcare expenditure.

The neurovascular embolization devices market size is expected to see strong growth in the next few years. It will grow to $1.60 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to expanding applications in emerging markets, emphasis on patient-centric care, rising awareness about neurovascular disorders, advancements in imaging technologies, and increasing investments in research and development. Major trends in the forecast period include personalized treatment approaches, integration of artificial intelligence in treatment planning, the emergence of next-generation embolic materials, shift towards outpatient and ambulatory procedures and development of innovative embolization techniques

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/neurovascular-embolization-devices-global-market-report

Segmentation & Regional Insights
The neurovascular embolization devices market covered in this report is segmented –

1) By Product: Embolization Coils, Liquid Embolic Systems, Flow Diversion Stents, Aneurysm Clips, Other Products
2) By Treatment: Ischemic Stroke Solution, Hemorrhagic Stroke Solutions
3) By Indication: Brain Aneurysms, Arteriovenous Malformation, Other Indications
4) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users

North America was the largest region in the neurovascular embolization devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurovascular embolization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15871&type=smp

Major Driver Impacting Market Growth
The rise in the prevalence of hemorrhages is expected to propel the neurovascular embolization devices market going forward. Hemorrhages are abnormal, uncontrolled bleeding that occurs internally within the body or externally through a break in the skin or mucous membrane. The prevalence of hemorrhages is due to several factors, such as aging populations, an increased incidence of hypertension, and the expanded use of anticoagulant medications. Neurovascular embolization devices are utilized in hemorrhagic strokes to obstruct abnormal blood vessels, reducing bleeding and preventing further damage to the brain. For instance, in February 2024, according to the research of King’s College London, a UK-based public research university, the number of cases and deaths from intracerebral hemorrhage (ICH) (a specific type of hemorrhage) is expected to increase by 59.4% in people aged 70 to 95 across the UK by 2050. Therefore, the rise in the prevalence of hemorrhages drives the growth of the neurovascular embolization devices market.

Key Industry Players
Major companies operating in the neurovascular embolization devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Heraeus Holding, Stryker Corporation, Boston Scientific Corporation, Kaneka Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc, Penumbra Inc, Asahi Intecc Co Ltd, MicroVention Inc, Balt USA LLC, Imperative Care Inc, InNeuroCo Inc, Acandis GmbH & Co KG, Rapid Medical Ltd, Emboline Inc, InspireMD Inc, QXMedical LLC, Vesalio LLC, EmbolX Inc

The neurovascular embolization devices market report table of contents includes:

1. Executive Summary

2. Neurovascular Embolization Devices Market Characteristics

3. Neurovascular Embolization Devices Market Trends And Strategies

4. Neurovascular Embolization Devices Market - Macro Economic Scenario

5. Global Neurovascular Embolization Devices Market Size and Growth
............

32. Global Neurovascular Embolization Devices Market Competitive Benchmarking

33. Global Neurovascular Embolization Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Neurovascular Embolization Devices Market

35. Neurovascular Embolization Devices Market Future Outlook and Potential Analysis

36. Appendix

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model